Sildenafil can be a strong and selective inhibitor of cGMP-specific phosphodiesterase variety five (PDE5), that is answerable for degradation of cGMP during the corpus cavernosum. The molecular framework of sildenafil is analogous to that of cGMP and acts to be a competitive binding agent of PDE5 during the corpus cavernosum, causing much more cGMP